U.S. federal trademark · Serial No. 88244187 · Reg. No. 6195846
medical treatment services, namely, the administration of gene therapy to patients involving harvesting a patient's cells, cloning their T-cell receptors from single cells, screening these receptors for desired specificities such as anti-tumor, transducing them into primary T-cells, and re-administration of the transduced T-cells back into the patient
scientific research and development services for direct cloning and screening T-cell receptors from single T-cells for desired specificities such as anti-tumor, and transducing them into primary T-cells for therapeutic use
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.